Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

Neuroendocrine cells in prostatic carcinoma

A Angelsen, H L Waldum, E Brenna

Human Pathology

|December 1, 1995

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Editorial: proton pump inhibitors (PPIs) and primary liver cancer.

Alimentary pharmacology & therapeutics·2018

Same author

Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Same author

Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.

Alimentary pharmacology & therapeutics·2015

Same author

The regulation of gastric acid secretion - clinical perspectives.

Acta physiologica (Oxford, England)·2013

Same author

Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.

Clinical and experimental immunology·2013

Same author

Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.

Alimentary pharmacology & therapeutics·2012

Related Experiment Videos

Neuroendocrine cells in prostatic carcinoma

Related Concept Videos

Related Articles

Editorial: proton pump inhibitors (PPIs) and primary liver cancer.

Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study.

Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.

The regulation of gastric acid secretion - clinical perspectives.

Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.

Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.